You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors.
New instrument releases at this week's meeting reflected proteomics' increased emphasis on throughput and the continuing spread of ion mobility technology.
Developed in collaboration with Waters and Labcyte, the platform enables applications including high-throughput drug screening and metabolomic profiling.
Labcyte has developed an acoustic droplet ejection technology called Echo that uses sound energy for the contactless transfer of samples and reagents.
Labcyte and the University of Helsinki's Institute for Molecular Medicine Finland have expanded their partnership to include multiple new applications.
Notable is adopting Labcyte's Echo acoustic liquid handling platform to screen cancer patients' tumor cells for response to individual and combination therapies.
The University's Institute for Molecular Medicine Finland will incorporate Labcyte's Echo acoustic liquid handling technology into multiple workflows.
The funds from Oxford Finance and Silicon Valley Bank will be used for R&D and commercialization of Labcyte's liquid handling systems.
Sample prep firm Labcyte said this week that it has received a $1 million Phase II small business innovation research grant for work on developing the company's acoustic liquid handling system as part of MALDI mass spec workflows.
NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded Labcyte $1 million to create a process for detecting cancer-associated proteins in samples, the company announced today.
Nature News reports on the US National Science Foundation's investigations of undisclosed foreign ties among researchers it funds.
Researchers have developed a set of 10 principles to guide how a list of all species on earth should be put together, the Guardian reports.
Wired reports on a new firm developing a gene writing approach for therapeutic genome changes.
In Nature this week: a method called cis-X combines whole-genome and transcriptome sequencing data to identify regulatory noncoding variants, and more.